Family · Pharmaceutical analytical standards

Human Anti-D Immunoglobulin

An immunoglobulin obtained from donor plasma, containing antibodies against the RhD antigen: given to Rh-negative mothers, it stops them becoming immunised against the Rh-positive blood of the foetus, preventing haemolytic disease of the newborn. It has been in use since 1968. This family brings together the active ingredient and other impurities.

Did you know?The first dose was given on 29 May 1968 to a mother in New Jersey; in 1980 John Gorman, Vincent Freda and William Pollack received the Lasker Award for this discovery.

Go to the active ingredient →

Structure not applicable: biological materialActive ingredientHuman Anti-D Immunoglobulin BRPCat. No. P-H028-001

Structure not applicable: biological materialImpurityB19 Virus DNA for NAT Testing BRPCat. No. P-H028-002

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Structure not applicable: biological materialBiological preparationB19 virus DNA for NAT testing BRPEDQM code Y0000285Family Human Anti-D Immunoglobulin

Structure not applicable: biological materialBiological preparationHuman Anti-D immunoglobulin BRPEDQM code Y0000219Family Human Anti-D Immunoglobulin

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.

See our services Contact us